A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer

Joseph C. Allegra, Thomas M. Woodcock, Stephen P. Richman, Kirby I. Bland, James L. Wittliff

Research output: Contribution to journalArticle

29 Scopus citations

Fingerprint Dive into the research topics of 'A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences